MARAbio
PrivateLast Round
Series A
Oct 8, 2024
Total Funding Raised
$19M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
MARAbio is a biotechnology company that develops a blood test to identify the risk of developing Maternal Autoantibody Related Autism (MARA).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MARAbio Comparables
Compare MARAbio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LinusBio | 80% | |
| Quadrant Biosciences Inc. | 77% | |
| BioROSA Technologies | 76% |
MARAbio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 8, 2024 |
MARAbio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MAK Capital One | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 128% MoM, reaching 4K.
- Jul 25, 2026
Monthly visitors grew 53% MoM.
MARAbio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access